Adaptive Cellular Immunity against African Swine Fever Virus Infections

African swine fever virus (ASFV) remains a threat to global pig populations. Infections with ASFV lead to a hemorrhagic disease with up to 100% lethality in Eurasian domestic and wild pigs. Although myeloid cells are the main target cells for ASFV, T cell responses are impacted by the infection as well. The complex responses remain not well understood, and, consequently, there is no commercially available vaccine. Here, we review the current knowledge about the induction of antiviral T cell responses by cells of the myeloid lineage, as well as T cell responses in infected animals, recent efforts in vaccine research, and T cell epitopes present in ASFV.

Medienart:

E-Artikel

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

Zur Gesamtaufnahme - volume:11

Enthalten in:

Pathogens (Basel, Switzerland) - 11(2022), 2 vom: 20. Feb.

Sprache:

Englisch

Beteiligte Personen:

Schäfer, Alexander [VerfasserIn]
Franzoni, Giulia [VerfasserIn]
Netherton, Christopher L [VerfasserIn]
Hartmann, Luise [VerfasserIn]
Blome, Sandra [VerfasserIn]
Blohm, Ulrike [VerfasserIn]

Links:

Volltext

Themen:

Adaptive immunity
African swine fever virus
Antigen-presenting cells
Cytokines
Journal Article
Porcine disease
Review
T cells
Vaccines

Anmerkungen:

Date Revised 10.03.2023

published: Electronic

Citation Status PubMed-not-MEDLINE

doi:

10.3390/pathogens11020274

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM337467242